Gene editing is suitable to treat GM1 Gangliosidosis: a proof-of-concept study

Delphine Leclerc(Inserm), David Gilot(Inserm)
bioRxiv (Cold Spring Harbor Laboratory)
April 17, 2022
Cited by 2


Related Papers